Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to develop fecal tests that will determine the extent of radiation exposure in patients undergoing radiation treatment for cancer. This project will determine whether fecal biomarkers can be used to diagnose exposure to radiation.
Patients undergoing TBI as part of a hematopoietic stem cell transplant (HSCT) will have feces collected for use in the validation and refinement of new methods for rapid radiation biodosimetry. The stool samples will be collected before, and at defined times after TBI. Stool sampling will occur in the same manner that it does during routine patient care during HSCT.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| TBI prior to stem cell transplantation |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To describe changes in gene expression associated with exposure to radiation | Changes in gene expression will be measured as abundance of RNA levels relative to the weight of feces | prior to TBI treatment (baseline) and up to 2 weeks following the last dose of TBI |
Not provided
Not provided
Inclusion Criteria:
Not provided
Not provided
Patients undergoing Total Body Irradiation (TBI) preceding hematopoietic stem cell transplantation.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John Baker, MD | Medical College of Wisconsin | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Children's Hospital of Wisconsin | Milwaukee | Wisconsin | 53226 | United States |
Not provided
Not provided
Not provided
Not provided
Stool